Reference List 2
Ambrosini PJ, Bianchi MD, Rabinovich H, Elia J
(1993), Antidepressant treatments in children
and adolescents.
In .Affective disorders. J Am Acad Child
Adolescent Psychiatry 32(1):1-6.
Amsterdam JD, Fawcett J, Quitkin FM et al.
(1997), Fluoxetine and norfluoxetine plasma
concentrations in major depression: a
multicenter study. Am J Psychiatry
154(7):963-969 [see comments].
Anderson IM, Tomenson BM (1994), The efficacy of
selective serotonin reuptake inhibitors in
depression: a meta-analysis of studies against
tricyclic antidepressants. Journal of
Psychopharmacology 8: 238-249.
Antonuccio DO, Danton WG, DeNelsky GY et al.
(1999), Raising questions about antidepressants.
Psychotherapy Psychosomatic 68(1):3-14.
Antonuccio DO, Thomas M, Danton WG (1997), A
cost-effectiveness analysis of cognitive
behavior therapy and Fluoxetine (Prozac) in the
treatment of depression. Behavior Therapy
28(2):187-210.
Antonuccio DO, Danton WG, DeNelsky GY (1995),
Psychotherapy versus medication for depression:
challenging the conventional wisdom with data.
Professional Psychology: Research and Practice
26(6):574-585.
Baxter LR Jr., Schwartz JM, Bergman KS et al.
(1992), Caudate glucose metabolic rate changes
with both drug and behavior therapy for
obsessive-compulsive disorder. Arch Gen
Psychiatry 49(9):681-689.
Biondi M (1995), Beyond the brain-mind dichotomy
and toward a common organizing principle of
pharmacological and psychological treatments.
Psychotherapy Psychosomatic 64(1):1-8.
Blatt SJ, Sanislow CA 3rd, Zuroff DC, Pilkonis
PA (1996), Characteristics of effective
therapists: further analyses of data from the
National Institute of Mental Health treatment of
depression collaborative research program. J
Consult Clin Psychol 64(6):1276-1284.
Blumenthal D, Campbell EG, Anderson MS et al.
(1997), Withholding research results in academic
life science. Evidence from a national survey of
faculty. JAMA 277(15):1224-1228.
Campbell EG, Louis KS, Blumenthal D (1998),
Looking a gift horse in the mouth: corporate
gifts supporting
life sciences research. JAMA 279(13):995-999
[see comments].
Cuijpers P (1997), Bibliotherapy in unipolar
depression: a meta-analysis. J Behav Ther Exp
Psychiatry 28(2): 139-147.
DeRubeis RJ, Gelfand LA, Tang TZ, Simons AD
(1999), Medications versus cognitive behavior
therapy for severely depressed outpatients:
mega-analysis of four randomized comparisons. Am
J Psychiatry 156(7):1007-1013.
Emslie GJ, Rush AJ, Weinberg WA et al. (1997), A
double-blind, randomized, placebo-controlled
trial of Fluoxetine in children and adolescents
with depression. Arch Gen Psychiatry
54(11):1031-1037.
Fisher S, Greenberg RP (1993), How sound is the
double-blind design for evaluating psychotropic
drugs? J Nerv Ment Dis 181(6):345-350.
Gram LF (1994), Fluoxetine. [Published erratum
appears in N Engl J Med 332(5):343.] N Engl J
Med 331 (20):1354- 1361.
Greenberg RP, Bornstein RF, Greenberg MD, Fisher
S (1992), A meta-analysis of antidepressant
outcome under "blinder" conditions. J Consult
Clin Psychol 60(5):664-669; discussion 670-677.
Greenberg RP, Fisher S (1997), Mood-mending
medicines: probing drug, psychotherapy, and
placebo solutions. In: From Placebo to Panacea:
Putting Psychiatric Drugs to the Test, Fisher S,
Greenberg RP, eds. New York: John Wiley & Sons
Inc., pp115-172.
Hazell P, O'Connell D, Heathcote D et al.
(1995), Efficacy of tricyclic drugs in treating
child and adolescent depression: a
meta-analysis. BMJ 310(6984):897-901.
Hollon SD, Shelton RC, Loosen PT (1991),
Cognitive therapy and pharmacotherapy for
depression. J Consult Clin Psychol 59(1):88-99.
Kirsch I, Sapirstein G (1998), Listening to
Prozac, but hearing placebo: a meta-analysis of
antidepressant medication. Treatment and
Prevention (article 0002a). Available at:
http://www.journals.apa.org/ treatment.
Accessed Feb. 22.
McKnight DL, Nelson-Gray RO, Barnhill J (1992),
Dexamethasone suppression test and response to
cognitive therapy and antidepressant medication.
Behavior Therapy 23(1):99-111.
Preskorn SH (1997), Clinically relevant
pharmacology of selective serotonin reuptake
inhibitors. An overview with emphasis on
pharmacokinetics and effects on oxidative drug
metabolism. Clin Pharmacokinet 32(suppl 1):1-21.
Segal ZV, Gemar M, Williams S (1999),
Differential cognitive response to a mood
challenge following successful cognitive therapy
or pharmacotherapy for unipolar depression. J
Abnorm Psychol 108(1):3-10.
Smith NM, Floyd MR, Scogin F, Jamison CS (1997),
Three-year follow-up of bibliotherapy for
depression. J Consult Clin Psychol
65(2):324-327.
Valenstein ES (1998), Blaming the Brain: The
Truth about Drugs and Mental Health. New York:
The Free Press. |
